The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes

Published:2020-12-29 Issue:3 Volume:23 Page:763-773
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

O'Hara Daniel V.¹²^ORCID,Parkhill Thomas R.¹³,Badve Sunil V.¹³^ORCID,Jun Min¹^ORCID,Jardine Meg J.¹⁴⁵^ORCID,Perkovic Vlado¹²^ORCID

Affiliation:

1. The George Institute for Global Health, UNSW Sydney Australia

2. Renal Department Royal North Shore Hospital Sydney Australia

3. Renal Department St George Hospital Sydney Australia

4. Renal Department Concord Repatriation General Hospital Sydney Australia

5. NHMRC Clinical Trials Centre University of Sydney Sydney Australia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14281

Reference40 articles.

1. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. A turning point for chronic kidney disease in diabetes

3. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

4. Worldwide access to treatment for end-stage kidney disease: a systematic review

5. Sitagliptin exerts anti-apoptotic effect in nephrotoxicity induced by cisplatin in rats

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of renal prognosis between dipeptidyl peptidase‐4 inhibitor users and non‐users;Diabetes, Obesity and Metabolism;2024-07-31

2. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature;Frontiers in Molecular Biosciences;2023-05-23

3. Take an individualized and multipronged approach when managing older adults with type 2 diabetes;Drugs & Therapy Perspectives;2023-04-11

4. Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis;Metabolism Open;2023-03

5. Letter to the Editor from Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”;The Journal of Clinical Endocrinology & Metabolism;2022-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3